UniProtKB - P21803 (FGFR2_MOUSE)
(max 400 entries)x
Your basket is currently empty.
Select item(s) and click on "Add to basket" to create your own collection here
(400 entries max)
Protein
Fibroblast growth factor receptor 2
Gene
Fgfr2
Organism
Mus musculus (Mouse)
Status
Functioni
Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, trophoblast function, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. Promotes cell proliferation in keratinocytes and immature osteoblasts, but promotes apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and PAK4. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal FGFR2 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1.4 Publications
Catalytic activityi
ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.PROSITE-ProRule annotation
Enzyme regulationi
Present in an inactive conformation in the absence of bound ligand. Ligand binding leads to dimerization and activation by autophosphorylation on tyrosine residues (By similarity).By similarity
Sites
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Binding sitei | 517 | ATPPROSITE-ProRule annotation | 1 | |
| Binding sitei | 571 | ATPPROSITE-ProRule annotation | 1 | |
| Active sitei | 626 | Proton acceptorPROSITE-ProRule annotation | 1 |
Regions
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Nucleotide bindingi | 487 – 495 | ATPPROSITE-ProRule annotation | 9 | |
| Nucleotide bindingi | 565 – 567 | ATPPROSITE-ProRule annotation | 3 |
GO - Molecular functioni
- ATP binding Source: UniProtKB-KW
- fibroblast growth factor-activated receptor activity Source: MGI
- fibroblast growth factor binding Source: MGI
- heparin binding Source: UniProtKB-KW
- protein homodimerization activity Source: MGI
GO - Biological processi
- angiogenesis Source: MGI
- animal organ morphogenesis Source: MGI
- apoptotic process Source: UniProtKB-KW
- axonogenesis Source: MGI
- bone development Source: MGI
- bone mineralization Source: MGI
- bone morphogenesis Source: MGI
- branch elongation involved in salivary gland morphogenesis Source: MGI
- branching involved in labyrinthine layer morphogenesis Source: MGI
- branching involved in prostate gland morphogenesis Source: MGI
- branching involved in salivary gland morphogenesis Source: MGI
- branching morphogenesis of a nerve Source: MGI
- bud elongation involved in lung branching Source: MGI
- cell-cell signaling Source: MGI
- cell fate commitment Source: MGI
- coronal suture morphogenesis Source: MGI
- digestive tract development Source: MGI
- embryonic cranial skeleton morphogenesis Source: MGI
- embryonic digestive tract morphogenesis Source: MGI
- embryonic organ development Source: MGI
- embryonic organ morphogenesis Source: MGI
- embryonic pattern specification Source: MGI
- endodermal digestive tract morphogenesis Source: MGI
- epidermis morphogenesis Source: MGI
- epithelial cell differentiation Source: MGI
- epithelial cell proliferation Source: MGI
- epithelial cell proliferation involved in salivary gland morphogenesis Source: MGI
- epithelial tube branching involved in lung morphogenesis Source: MGI
- fibroblast growth factor receptor signaling pathway Source: MGI
- fibroblast growth factor receptor signaling pathway involved in hemopoiesis Source: UniProtKB
- fibroblast growth factor receptor signaling pathway involved in mammary gland specification Source: MGI
- fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow Source: UniProtKB
- fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development Source: UniProtKB
- fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow Source: UniProtKB
- gland morphogenesis Source: MGI
- hair follicle morphogenesis Source: MGI
- inner ear morphogenesis Source: MGI
- in utero embryonic development Source: MGI
- lacrimal gland development Source: MGI
- lateral sprouting from an epithelium Source: MGI
- lens fiber cell development Source: MGI
- limb bud formation Source: MGI
- lung alveolus development Source: MGI
- lung-associated mesenchyme development Source: MGI
- lung development Source: MGI
- lung lobe morphogenesis Source: MGI
- mammary gland bud formation Source: MGI
- membranous septum morphogenesis Source: MGI
- mesenchymal cell differentiation Source: MGI
- mesenchymal cell differentiation involved in lung development Source: MGI
- mesenchymal cell proliferation involved in lung development Source: MGI
- midbrain development Source: MGI
- morphogenesis of embryonic epithelium Source: MGI
- multicellular organism growth Source: MGI
- negative regulation of cell proliferation Source: MGI
- negative regulation of mitotic nuclear division Source: MGI
- negative regulation of transcription from RNA polymerase II promoter Source: MGI
- neuromuscular junction development Source: MGI
- odontogenesis Source: MGI
- orbitofrontal cortex development Source: UniProtKB
- organ growth Source: MGI
- otic vesicle formation Source: MGI
- outflow tract septum morphogenesis Source: MGI
- peptidyl-tyrosine phosphorylation Source: MGI
- positive regulation of canonical Wnt signaling pathway Source: MGI
- positive regulation of cardiac muscle cell proliferation Source: MGI
- positive regulation of cell cycle Source: UniProtKB
- positive regulation of cell division Source: MGI
- positive regulation of cell proliferation Source: UniProtKB
- positive regulation of epithelial cell proliferation Source: MGI
- positive regulation of epithelial cell proliferation involved in lung morphogenesis Source: MGI
- positive regulation of ERK1 and ERK2 cascade Source: MGI
- positive regulation of gene expression Source: MGI
- positive regulation of MAPK cascade Source: MGI
- positive regulation of mesenchymal cell proliferation Source: MGI
- positive regulation of phospholipase activity Source: MGI
- positive regulation of transcription from RNA polymerase II promoter Source: UniProtKB
- positive regulation of Wnt signaling pathway Source: MGI
- post-embryonic development Source: MGI
- prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis Source: MGI
- prostate epithelial cord elongation Source: MGI
- prostate gland morphogenesis Source: MGI
- protein autophosphorylation Source: MGI
- pyramidal neuron development Source: UniProtKB
- regulation of branching involved in prostate gland morphogenesis Source: MGI
- regulation of cell fate commitment Source: MGI
- regulation of cell proliferation Source: MGI
- regulation of epithelial cell proliferation Source: MGI
- regulation of ERK1 and ERK2 cascade Source: MGI
- regulation of fibroblast growth factor receptor signaling pathway Source: MGI
- regulation of morphogenesis of a branching structure Source: MGI
- regulation of multicellular organism growth Source: MGI
- regulation of smoothened signaling pathway Source: MGI
- regulation of smooth muscle cell differentiation Source: MGI
- reproductive structure development Source: MGI
- squamous basal epithelial stem cell differentiation involved in prostate gland acinus development Source: MGI
- synaptic vesicle transport Source: MGI
- ureteric bud development Source: MGI
- vasculogenesis involved in coronary vascular morphogenesis Source: DFLAT
- ventricular cardiac muscle tissue morphogenesis Source: MGI
- ventricular zone neuroblast division Source: UniProtKB
Keywordsi
| Molecular function | Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase |
| Biological process | Apoptosis |
| Ligand | ATP-binding, Nucleotide-binding |
Enzyme and pathway databases
| BRENDAi | 2.7.10.1. 3474. |
Names & Taxonomyi
| Protein namesi | Recommended name: Fibroblast growth factor receptor 2 (EC:2.7.10.1)Short name: FGFR-2 Alternative name(s): Keratinocyte growth factor receptor Short name: KGFR CD_antigen: CD332 |
| Gene namesi | Name:Fgfr2 Synonyms:Bek, Ect1 |
| Organismi | Mus musculus (Mouse) |
| Taxonomic identifieri | 10090 [NCBI] |
| Taxonomic lineagei | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Myomorpha › Muroidea › Muridae › Murinae › Mus › Mus |
| Proteomesi |
|
Organism-specific databases
| MGIi | MGI:95523. Fgfr2. |
Subcellular locationi
- Cell membrane; Single-pass type I membrane protein
- Golgi apparatus By similarity
- Cytoplasmic vesicle By similarity
Note: Detected on osteoblast plasma membrane lipid rafts. After ligand binding, the activated receptor is rapidly internalized and degraded (By similarity).By similarity
Topology
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Topological domaini | 22 – 377 | ExtracellularSequence analysisAdd BLAST | 356 | |
| Transmembranei | 378 – 398 | HelicalSequence analysisAdd BLAST | 21 | |
| Topological domaini | 399 – 821 | CytoplasmicSequence analysisAdd BLAST | 423 |
GO - Cellular componenti
- cell cortex Source: MGI
- cell surface Source: MGI
- cytoplasm Source: MGI
- cytoplasmic vesicle Source: UniProtKB-KW
- excitatory synapse Source: UniProtKB
- extracellular region Source: MGI
- Golgi apparatus Source: UniProtKB-SubCell
- integral component of plasma membrane Source: MGI
- intracellular membrane-bounded organelle Source: MGI
- nucleoplasm Source: MGI
- nucleus Source: MGI
Keywords - Cellular componenti
Cell membrane, Cytoplasmic vesicle, Golgi apparatus, MembranePathology & Biotechi
Disruption phenotypei
Embryonic lethality shortly after implantation, due to trophoblast defects, absence of a functional placenta, failure of limb bud formation, plus defects in lung branching and heart development.4 Publications
Mutagenesis
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Mutagenesisi | 769 | Y → F: Abolishes phosphorylation of FRS2 and activation of MAP kinases. 1 Publication | 1 |
Keywords - Diseasei
Proto-oncogeneChemistry databases
| ChEMBLi | CHEMBL2111391. |
PTM / Processingi
Molecule processing
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Signal peptidei | 1 – 21 | Add BLAST | 21 | |
| ChainiPRO_0000016784 | 22 – 821 | Fibroblast growth factor receptor 2Add BLAST | 800 |
Amino acid modifications
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Disulfide bondi | 62 ↔ 107 | PROSITE-ProRule annotation | ||
| Glycosylationi | 83 | N-linked (GlcNAc...) asparagineSequence analysis | 1 | |
| Glycosylationi | 123 | N-linked (GlcNAc...) asparagineSequence analysis | 1 | |
| Glycosylationi | 147 | N-linked (GlcNAc...) asparagineSequence analysis | 1 | |
| Disulfide bondi | 179 ↔ 231 | PROSITE-ProRule annotation | ||
| Glycosylationi | 228 | N-linked (GlcNAc...) asparagineSequence analysis | 1 | |
| Glycosylationi | 241 | N-linked (GlcNAc...) asparagineSequence analysis | 1 | |
| Glycosylationi | 265 | N-linked (GlcNAc...) asparagineSequence analysis | 1 | |
| Disulfide bondi | 278 ↔ 342 | PROSITE-ProRule annotation | ||
| Glycosylationi | 297 | N-linked (GlcNAc...) asparagineSequence analysis | 1 | |
| Glycosylationi | 318 | N-linked (GlcNAc...) asparagineSequence analysis | 1 | |
| Glycosylationi | 331 | N-linked (GlcNAc...) asparagineSequence analysis | 1 | |
| Modified residuei | 466 | Phosphotyrosine; by autocatalysisBy similarity | 1 | |
| Modified residuei | 586 | Phosphotyrosine; by autocatalysisBy similarity | 1 | |
| Modified residuei | 588 | Phosphotyrosine; by autocatalysisBy similarity | 1 | |
| Modified residuei | 656 | Phosphotyrosine; by autocatalysisBy similarity | 1 | |
| Modified residuei | 657 | Phosphotyrosine; by autocatalysisBy similarity | 1 | |
| Modified residuei | 769 | Phosphotyrosine; by autocatalysisBy similarity | 1 | |
| Modified residuei | 780 | PhosphoserineBy similarity | 1 |
Post-translational modificationi
Autophosphorylated. Binding of FGF family members together with heparan sulfate proteoglycan or heparin promotes receptor dimerization and autophosphorylation on tyrosine residues. Autophosphorylation occurs in trans between the two FGFR molecules present in the dimer (By similarity).By similarity
N-glycosylated in the endoplasmic reticulum. The N-glycan chains undergo further maturation to an Endo H-resistant form in the Golgi apparatus (By similarity).By similarity
Ubiquitinated. FGFR2 is rapidly ubiquitinated after autophosphorylation, leading to internalization and degradation. Subject to degradation both in lysosomes and by the proteasome (By similarity).By similarity
Keywords - PTMi
Disulfide bond, Glycoprotein, Phosphoprotein, Ubl conjugationProteomic databases
| MaxQBi | P21803. |
| PaxDbi | P21803. |
| PRIDEi | P21803. |
PTM databases
| iPTMneti | P21803. |
| PhosphoSitePlusi | P21803. |
Interactioni
Subunit structurei
Monomer. Homodimer after ligand binding. Interacts predominantly with FGF1 and FGF2, but can also interact with FGF3, FGF4, FGF6, FGF7, FGF8, FGF9, FGF10, FGF17, FGF18 and FGF22 (in vitro) (PubMed:8663044). Ligand specificity is determined by tissue-specific expression of isoforms, and differences in the third Ig-like domain are crucial for ligand specificity. Affinity for fibroblast growth factors (FGFs) is increased by heparan sulfate glycosaminoglycans that function as coreceptors. Likewise, KLB increases the affinity for FGF19 and FGF21. Interacts with PLCG1 (PubMed:15629145). Interacts with GRB2 and PAK4 (By similarity). Interacts with FLRT2 (PubMed:21765038).By similarity3 Publications
Binary interactionsi
| With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| Ncam1 | P13595 | 2 | EBI-6286942,EBI-774943 |
GO - Molecular functioni
- fibroblast growth factor binding Source: MGI
- protein homodimerization activity Source: MGI
Protein-protein interaction databases
| BioGridi | 199657. 2 interactors. |
| DIPi | DIP-6038N. |
| IntActi | P21803. 2 interactors. |
| STRINGi | 10090.ENSMUSP00000112430. |
Structurei
Secondary structure
Legend: HelixTurnBeta strandPDB Structure known for this area
Show more details| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Beta strandi | 48 – 52 | Combined sources | 5 | |
| Beta strandi | 58 – 61 | Combined sources | 4 | |
| Beta strandi | 69 – 74 | Combined sources | 6 | |
| Beta strandi | 77 – 79 | Combined sources | 3 | |
| Beta strandi | 83 – 88 | Combined sources | 6 | |
| Beta strandi | 91 – 94 | Combined sources | 4 | |
| Helixi | 99 – 101 | Combined sources | 3 | |
| Beta strandi | 103 – 110 | Combined sources | 8 | |
| Beta strandi | 115 – 124 | Combined sources | 10 |
3D structure databases
| Select the link destinations: PDBei RCSB PDBi PDBji Links Updated | PDB entry | Method | Resolution (Å) | Chain | Positions | PDBsum |
| 4HWU | X-ray | 2.90 | A/B | 45-127 | [»] | |
| ProteinModelPortali | P21803. | |||||
| SMRi | P21803. | |||||
| ModBasei | Search... | |||||
| MobiDBi | Search... | |||||
Family & Domainsi
Domains and Repeats
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Domaini | 25 – 125 | Ig-like C2-type 1Add BLAST | 101 | |
| Domaini | 154 – 247 | Ig-like C2-type 2Add BLAST | 94 | |
| Domaini | 256 – 358 | Ig-like C2-type 3Add BLAST | 103 | |
| Domaini | 481 – 770 | Protein kinasePROSITE-ProRule annotationAdd BLAST | 290 |
Region
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Regioni | 161 – 178 | Heparin-bindingBy similarityAdd BLAST | 18 |
Domaini
The second and third Ig-like domains directly interact with fibroblast growth factors (FGF) and heparan sulfate proteoglycans. Alternative splicing events affecting the third Ig-like domain are crucial for ligand selectivity (By similarity).By similarity
Sequence similaritiesi
Belongs to the protein kinase superfamily. Tyr protein kinase family. Fibroblast growth factor receptor subfamily.PROSITE-ProRule annotation
Keywords - Domaini
Immunoglobulin domain, Repeat, Signal, Transmembrane, Transmembrane helixPhylogenomic databases
| eggNOGi | KOG0200. Eukaryota. COG0515. LUCA. |
| HOGENOMi | HOG000263410. |
| HOVERGENi | HBG000345. |
| InParanoidi | P21803. |
| KOi | K05093. |
| PhylomeDBi | P21803. |
Family and domain databases
| Gene3Di | 2.60.40.10. 3 hits. |
| InterProi | View protein in InterPro IPR028175. FGF_rcpt_2. IPR016248. FGF_rcpt_fam. IPR007110. Ig-like_dom. IPR013783. Ig-like_fold. IPR013098. Ig_I-set. IPR003599. Ig_sub. IPR003598. Ig_sub2. IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_dom. IPR017441. Protein_kinase_ATP_BS. IPR001245. Ser-Thr/Tyr_kinase_cat_dom. IPR008266. Tyr_kinase_AS. IPR020635. Tyr_kinase_cat_dom. |
| PANTHERi | PTHR24416:SF468. PTHR24416:SF468. 1 hit. |
| Pfami | View protein in Pfam PF07679. I-set. 2 hits. PF07714. Pkinase_Tyr. 1 hit. |
| PIRSFi | PIRSF000628. FGFR. 1 hit. |
| PRINTSi | PR00109. TYRKINASE. |
| SMARTi | View protein in SMART SM00409. IG. 3 hits. SM00408. IGc2. 3 hits. SM00219. TyrKc. 1 hit. |
| SUPFAMi | SSF48726. SSF48726. 3 hits. SSF56112. SSF56112. 1 hit. |
| PROSITEi | View protein in PROSITE PS50835. IG_LIKE. 3 hits. PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00109. PROTEIN_KINASE_TYR. 1 hit. |
Sequences (2)i
Sequence statusi: Complete.
Sequence processingi: The displayed sequence is further processed into a mature form.
This entry describes 2 isoformsi produced by alternative splicing. AlignAdd to basket
Isoform Long (identifier: P21803-1) [UniParc]FASTAAdd to basket
This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
10 20 30 40 50
MVSWGRFICL VLVTMATLSL ARPSFSLVED TTLEPEEPPT KYQISQPEAY
60 70 80 90 100
VVAPGESLEL QCMLKDAAVI SWTKDGVHLG PNNRTVLIGE YLQIKGATPR
110 120 130 140 150
DSGLYACTAA RTVDSETWIF MVNVTDAISS GDDEDDTDSS EDVVSENRSN
160 170 180 190 200
QRAPYWTNTE KMEKRLHACP AANTVKFRCP AGGNPTSTMR WLKNGKEFKQ
210 220 230 240 250
EHRIGGYKVR NQHWSLIMES VVPSDKGNYT CLVENEYGSI NHTYHLDVVE
260 270 280 290 300
RSPHRPILQA GLPANASTVV GGDVEFVCKV YSDAQPHIQW IKHVEKNGSK
310 320 330 340 350
NGPDGLPYLK VLKAAGVNTT DKEIEVLYIR NVTFEDAGEY TCLAGNSIGI
360 370 380 390 400
SFHSAWLTVL PAPVREKEIT ASPDYLEIAI YCIGVFLIAC MVVTVIFCRM
410 420 430 440 450
KTTTKKPDFS SQPAVHKLTK RIPLRRQVTV SAESSSSMNS NTPLVRITTR
460 470 480 490 500
LSSTADTPML AGVSEYELPE DPKWEFPRDK LTLGKPLGEG CFGQVVMAEA
510 520 530 540 550
VGIDKDKPKE AVTVAVKMLK DDATEKDLSD LVSEMEMMKM IGKHKNIINL
560 570 580 590 600
LGACTQDGPL YVIVEYASKG NLREYLRARR PPGMEYSYDI NRVPEEQMTF
610 620 630 640 650
KDLVSCTYQL ARGMEYLASQ KCIHRDLAAR NVLVTENNVM KIADFGLARD
660 670 680 690 700
INNIDYYKKT TNGRLPVKWM APEALFDRVY THQSDVWSFG VLMWEIFTLG
710 720 730 740 750
GSPYPGIPVE ELFKLLKEGH RMDKPTNCTN ELYMMMRDCW HAVPSQRPTF
760 770 780 790 800
KQLVEDLDRI LTLTTNEEYL DLTQPLEQYS PSYPDTSSSC SSGDDSVFSP
810 820
DPMPYEPCLP QYPHINGSVK T
Isoform Short (identifier: P21803-2) [UniParc]FASTAAdd to basket
The sequence of this isoform differs from the canonical sequence as follows:
37-37: E → G
38-152: Missing.
314-361: AAGVNTTDKE...FHSAWLTVLP → HSGINSSNAE...AWLTVLPKQQ
Experimental Info
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Sequence conflicti | 53 | A → V in CAA39083 (PubMed:1711190).Curated | 1 | |
| Sequence conflicti | 55 – 56 | GE → RG in CAA39083 (PubMed:1711190).Curated | 2 | |
| Sequence conflicti | 90 | E → R in CAA39083 (PubMed:1711190).Curated | 1 | |
| Sequence conflicti | 119 | I → Y in CAA39083 (PubMed:1711190).Curated | 1 | |
| Sequence conflicti | 142 – 143 | DV → R in CAA39083 (PubMed:1711190).Curated | 2 | |
| Sequence conflicti | 169 | C → V in CAA39083 (PubMed:1711190).Curated | 1 | |
| Sequence conflicti | 169 | C → V in AAA39377 (PubMed:1846048).Curated | 1 | |
| Sequence conflicti | 187 | S → P in CAA39083 (PubMed:1711190).Curated | 1 | |
| Sequence conflicti | 187 | S → P in AAA39377 (PubMed:1846048).Curated | 1 | |
| Sequence conflicti | 214 | W → R in CAA39083 (PubMed:1711190).Curated | 1 | |
| Sequence conflicti | 229 | Y → I in CAA39083 (PubMed:1711190).Curated | 1 | |
| Sequence conflicti | 275 | E → R in CAA39083 (PubMed:1711190).Curated | 1 | |
| Sequence conflicti | 301 | N → Y in CAA39083 (PubMed:1711190).Curated | 1 | |
| Sequence conflicti | 301 | N → Y in AAA39377 (PubMed:1846048).Curated | 1 |
Alternative sequence
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Alternative sequenceiVSP_002985 | 37 | E → G in isoform Short. 1 Publication | 1 | |
| Alternative sequenceiVSP_002986 | 38 – 152 | Missing in isoform Short. 1 PublicationAdd BLAST | 115 | |
| Alternative sequenceiVSP_002987 | 314 – 361 | AAGVN…LTVLP → HSGINSSNAEVLALFNVTEM DAGEYICKVSNYIGQANQSA WLTVLPKQQ in isoform Short. 1 PublicationAdd BLAST | 48 |
Sequence databases
| Select the link destinations: EMBLi GenBanki DDBJi Links Updated | X55441 mRNA. Translation: CAA39083.1. M63503 mRNA. Translation: AAA39377.1. M86441 mRNA. Translation: AAA37286.1. Y16152 Genomic DNA. Translation: CAA76098.1. Y16167 Genomic DNA. Translation: CAA76099.1. M23362 mRNA. Translation: AAA37285.1. |
| PIRi | A38429. A44142. TVMSBK. S17295. |
| RefSeqi | NP_034337.2. NM_010207.2. NP_963895.2. NM_201601.2. |
| UniGenei | Mm.16340. |
Genome annotation databases
| GeneIDi | 14183. |
| KEGGi | mmu:14183. |
Keywords - Coding sequence diversityi
Alternative splicingSimilar proteinsi
Links to similar proteins from the UniProt Reference Clusters (UniRef) at 100%, 90% and 50% sequence identity:| 100% | UniRef100 combines identical sequences and sub-fragments with 11 or more residues from any organism into one UniRef entry. |
| 90% | UniRef90 is built by clustering UniRef100 sequences that have at least 90% sequence identity to, and 80% overlap with, the longest sequence (a.k.a seed sequence). |
| 50% | UniRef50 is built by clustering UniRef90 seed sequences that have at least 50% sequence identity to, and 80% overlap with, the longest sequence in the cluster. |
Entry informationi
| Entry namei | FGFR2_MOUSE | |
| Accessioni | P21803Primary (citable) accession number: P21803 Secondary accession number(s): O55141, Q00389, Q61342 | |
| Entry historyi | Integrated into UniProtKB/Swiss-Prot: | May 1, 1991 |
| Last sequence update: | November 1, 1997 | |
| Last modified: | May 10, 2017 | |
| This is version 171 of the entry and version 4 of the sequence. See complete history. | ||
| Entry statusi | Reviewed (UniProtKB/Swiss-Prot) | |
| Annotation program | Chordata Protein Annotation Program | |
Miscellaneousi
Keywords - Technical termi
3D-structure, Complete proteome, Reference proteomeDocuments
- MGD cross-references
Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot - PDB cross-references
Index of Protein Data Bank (PDB) cross-references - Human and mouse protein kinases
Human and mouse protein kinases: classification and index - SIMILARITY comments
Index of protein domains and families
